MarketWatch.com - Top Stories

Pfizer sticks to 2025 profit view as it shrugs off plunging Paxlovid sales for COVID

Pfizer’s first-quarter revenue missed analyst estimates as it faces an “uncertain and volatile external environment.”

Apr 29, 2025 - 13:50
 0
Pfizer sticks to 2025 profit view as it shrugs off plunging Paxlovid sales for COVID
Pfizer’s first-quarter revenue missed analyst estimates as it faces an “uncertain and volatile external environment.”
Read More

Tags:

Previous Article

DGRO: Earnings Growth Is Likely To Drive Returns In 2025 And Beyond

Next Article

U.S. trade deficit in goods soars to all-time high as businesses aimed to beat T...

Related Posts

Globalization isn’t over — but now it’s costly and will make Americans poorer

Globalization isn’t over — but now it’s costly and will...

Apr 22, 2025  0

Why Apple investors might be too optimistic about what’s ahead

Why Apple investors might be too optimistic about what’...

Apr 23, 2025  0

The stock market is looking oversold as earnings season gets underway

The stock market is looking oversold as earnings season...

Apr 24, 2025  0